NOVARTIS AG (NVS) — insider trading
NOVARTIS AG (NVS) has 18 reported SEC Form 4 insider transactions in our data, including 1 open-market purchase and 11 open-market sales among the most recent 18 (latest 2020-07-14).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2020-07-14 | NOVARTIS PHARMA AG; NOVARTIS AG | 10% owner | Conversion of derivative (derivative) | 7,367,387 | — | — | Form 4 |
| 2020-07-14 | NOVARTIS PHARMA AG; NOVARTIS AG | 10% owner | Conversion of derivative | 5,908,089 | — | — | Form 4 |
| 2020-06-30 | Novartis Bioventures Ltd; NOVARTIS AG | Other | Conversion of derivative (derivative) | 199,996 | $0.00 | $0 | Form 4 |
| 2020-06-30 | Novartis Bioventures Ltd; NOVARTIS AG | Other | Conversion of derivative (derivative) | 856,262 | $0.00 | $0 | Form 4 |
| 2020-06-30 | Novartis Bioventures Ltd; NOVARTIS AG | Other | Open-market purchase | 125,000 | $17.00 | $2.13M | Form 4 |
| 2020-06-30 | Novartis Bioventures Ltd; NOVARTIS AG | Other | Conversion of derivative | 199,996 | — | — | Form 4 |
| 2020-06-30 | Novartis Bioventures Ltd; NOVARTIS AG | Other | Conversion of derivative | 856,262 | — | — | Form 4 |
| 2020-06-19 | Novartis Bioventures Ltd; NOVARTIS AG | Other | Open-market sale | 1,001,312 | $8.25 | $8.26M | Form 4 |
| 2020-06-18 | Novartis Bioventures Ltd; NOVARTIS AG | Other | Open-market sale | 900 | $9.04 | $8.1K | Form 4 |
| 2020-06-17 | Novartis Bioventures Ltd; NOVARTIS AG | 10% owner | Open-market sale | 4,622 | $9.27 | $42.8K | Form 4 |
| 2020-06-16 | Novartis Bioventures Ltd; NOVARTIS AG | 10% owner | Open-market sale | 8,600 | $9.30 | $80.0K | Form 4 |
| 2020-06-15 | Novartis Bioventures Ltd; NOVARTIS AG | 10% owner | Open-market sale | 6,164 | $9.05 | $55.8K | Form 4 |
| 2020-06-12 | Novartis Bioventures Ltd; NOVARTIS AG | 10% owner | Open-market sale | 1,500 | $9.19 | $13.8K | Form 4 |
| 2020-06-11 | Novartis Bioventures Ltd; NOVARTIS AG | 10% owner | Open-market sale | 7,200 | $9.21 | $66.3K | Form 4 |
| 2020-06-10 | Novartis Bioventures Ltd; NOVARTIS AG | 10% owner | Open-market sale | 8,532 | $9.46 | $80.7K | Form 4 |
| 2020-06-09 | Novartis Bioventures Ltd; NOVARTIS AG | 10% owner | Open-market sale | 7,000 | $9.38 | $65.7K | Form 4 |
| 2020-06-08 | Novartis Bioventures Ltd; NOVARTIS AG | 10% owner | Open-market sale | 5,659 | $9.66 | $54.7K | Form 4 |
| 2020-06-05 | Novartis Bioventures Ltd; NOVARTIS AG | 10% owner | Open-market sale | 8,652 | $9.66 | $83.6K | Form 4 |
Ask the chat about NVS's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: NOVARTIS AG (NVS).
Last updated 2020-07-14 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.